ArticleBMC pharmacology & toxicology2025

Real-world safety analysis of deutetrabenazine post-marketing: a disproportionality study leveraging the FDA Adverse Event Reporting System (FAERS) database.

Guangwei Qing et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.